BioCentury This Week

Ep. 290 - Biotech Survey Sees Tough Days Ahead. Plus: FDA, China Speed

Ep. 289 - Replacing Animal Models. Plus: RFK Jr. & FDA

Ep. 288 - FDA and Tariffs Turmoil, and AACR Preview

Ep. 287 - The Bear is Back: Marks’ Ouster, Tariffs and a Tumbling XBI

Ep. 286 - Sofinnova’s Pan-European Accelerator, China Biotechs, Trump Tariffs

Ep. 285 - BIO's Trump 2.0 Plan. Plus: Autoimmune CAR Ts & Telix's Radiopharma Play

Ep. 284 - Takeaways from the East-West Summit

This BioCentury This Week podcast, recorded live from the BioCentury East-West Biopharma Summit in Singapore, discusses key takeaways from the event. The panel, comprised of BioCentury staff and industry executives, covers themes such as the impact of tough capital markets on the biopharma industry, the rise of the NU...

Ep. 283 - Makary’s FDA Agenda, Amylin in Obesity and Life After DEI

Ep. 282 - CRISPR Lessons: Plus, AbbVie Enters Obesity

Ep. 281 - Roche Reboot and 5 Things on Trump 2.0

Ep. 280 - China Competition. Plus: FDA Firings and Biotech IPOs

Ep. 279 - East-West Summit Preview

Ep. 278 - Trump 2.0’s Impact on FDA, NIH. Plus: Precision Medicine

Ep. 277 - Asia's NewCo Model, FDA Tipping Point, Vertex's Pain Drug

Ep. 276 - Precision Neuropsychiatry Spotlight With ICON's Peter Schueler

Ep. 275 - Series As & Innovation. Plus: Rocky Transition at FDA, NIH

Ep. 274 - 2025 Biotech Preview: Markets, Catalysts and AI

Ep. 273 - JPM 2025 Wrap: Sunny Skies & Megarounds

Ep. 272 - JPM Deal Buzz & Rep. Auchincloss’ Take on Biopharma

Ep. 271 - Biotech in the New Year. Plus: Beyond Biosecure